Potent and Selective Nonpeptidic Inhibitors of Procollagen C-Proteinase
摘要:
6-Cyclohexyl-N-hydroxy-3-(1,2,4-oxadiazol-5-yl)hexanamides were previously disclosed as inhibitors of procollagen C-proteinase (PCP) culminating in the identification of amide 1. Our objective was to discover a second inhibitor that would have improved affinity for PCP and to optimize properties for transepidermal delivery (TED) to intact skin. Further investigation of this template identified a number of potent PCP inhibitors (IC50 values of 2-6 nM) with improved TED flux. Sulfonamide 56 had excellent PCP enzyme activity when measured with a peptide substrate (K-i 8.7 nM) or with the endogenous substrate procollagen (IC50 3.4 nM) and demonstrates excellent selectivity over MMPs involved in wound healing (> 10 000-fold). In the fibroplasia model, 56 inhibited deposition of insoluble collagen by 76 +/- 2% at 10 mu M and was very effective at penetrating human skin in vitro with a TED flux of 1.5 mu g/cm(2)/h, which compares favorably with values for agents that are known to penetrate skin well in vivo. Based on this profile, 56 (UK-421,045) was selected as a candidate for further preclinical evaluation as a topically applied, dermal anti-scarring agent.
3-ox(adi) azolylpropanohydroxamic acids useful as procollagen C- Proteinase inhibitors
申请人:——
公开号:US20020151535A1
公开(公告)日:2002-10-17
Compounds of formula (I):
1
wherein the substituents are as defined herein, and their salt, solvates, and prodrugs are procollagen C-proteinase (PCP) inhibitors useful in treating conditions mediated by PCP.
An efficient synthesis of unsymmetrical 2,6-disubstituted pyrazines was developed via a palladium(II)-catalyzed cascade reaction from aminoacetonitriles and arylboronic acids. This transformation involves a C(sp)–C(sp2) coupling followed by an intramolecular C–N bondformation in good to excellent yields.
通过钯 (II) 催化的氨基乙腈和芳基硼酸的级联反应,开发了不对称 2,6-二取代吡嗪的有效合成。这种转化涉及 C(sp)–C(sp 2 ) 偶联,然后是分子内 C–N 键的形成,收率非常好。
作者:Alan R. Katritzky、Daniela C. Oniciu、Ion Ghiviriga
DOI:10.1080/00397919708004211
日期:1997.3
N-(alpha-Benzotriazol-1-ylalkyl)sulfonamides, readily available from benzotriazole, an aldehyde and a sulfonamide, are converted into the corresponding N-(alpha-cyanoalkyl)sulfonamides in good yields by treatment with potassium cyanide.
The CSIC Reaction on Substrates Derived From Aldehydes
作者:José L Marco、Simon T Ingate、Carlos Jaime、Ivan Beá
DOI:10.1016/s0040-4020(00)00124-1
日期:2000.4
The Carbanion-mediated Sulfonate (Sulfonamide) Intramolecular Cyclization reaction (CSIC reaction) on conveniently functionalized cyanoalkylsulfonates and cyanoalkylsulfonamides derivedfromaldehydes is possible and gives the new heterocyclic ring systems 5-alkyl-4-amino-5H-1,2-oxathiole 2,2-dioxide and 3-alkyl-5H-4-amino-5-cyano-5H-2,3-dihydroisothiazole 1,1-dioxide in good yield.
在方便官能化的氰基烷基磺酸盐和衍生自醛的氰基烷基磺酰胺上进行碳负离子介导的磺酸盐(磺酰胺)分子内环化反应(CSIC反应),可以得到新的杂环体系5-烷基-4-氨基-5 H -1,2-恶唑2 ,2-二氧化物和3-烷基-5 H -4-氨基-5-氰基-5 H -2,3-二氢异噻唑1,1-二氧化物的收率很好。
Potent and Selective Nonpeptidic Inhibitors of Procollagen C-Proteinase
作者:Paul V. Fish、Gillian A. Allan、Simon Bailey、Julian Blagg、Richard Butt、Michael G. Collis、Doris Greiling、Kim James、Jackie Kendall、Andrew McElroy、Dawn McCleverty、Charlotte Reed、Robert Webster、Gavin A. Whitlock
DOI:10.1021/jm061010z
日期:2007.7.1
6-Cyclohexyl-N-hydroxy-3-(1,2,4-oxadiazol-5-yl)hexanamides were previously disclosed as inhibitors of procollagen C-proteinase (PCP) culminating in the identification of amide 1. Our objective was to discover a second inhibitor that would have improved affinity for PCP and to optimize properties for transepidermal delivery (TED) to intact skin. Further investigation of this template identified a number of potent PCP inhibitors (IC50 values of 2-6 nM) with improved TED flux. Sulfonamide 56 had excellent PCP enzyme activity when measured with a peptide substrate (K-i 8.7 nM) or with the endogenous substrate procollagen (IC50 3.4 nM) and demonstrates excellent selectivity over MMPs involved in wound healing (> 10 000-fold). In the fibroplasia model, 56 inhibited deposition of insoluble collagen by 76 +/- 2% at 10 mu M and was very effective at penetrating human skin in vitro with a TED flux of 1.5 mu g/cm(2)/h, which compares favorably with values for agents that are known to penetrate skin well in vivo. Based on this profile, 56 (UK-421,045) was selected as a candidate for further preclinical evaluation as a topically applied, dermal anti-scarring agent.